Lorne Cancer: The discovery of a key weakness in metastatic melanoma is a Sputnik moment in the treatment of this deadly cancer. Although Professor Richard Kefford thinks we’re still a long way from landing on the moon. [ + ]

AusBiotech has relaunched the employment section on its high-traffic website, giving members the opportunity to list vacancies free and qualified industry professionals access to the latest list of industry jobs. [ + ]

A diagnosis technique developed by researchers at the Riken Omics Science Center (OSC) has succeeded in detecting influenza virus infection in only 40 minutes and with 100 times the sensitivity of conventional methods. [ + ]

The science and research partnership between Australia and China has been put under the microscope in a report released by Minister for Science and Research, Senator Chris Evans. The report, Science and Research Collaboration between Australia and China, provides a detailed analysis of the growing links between Australia and its most important trading partner. [ + ]

Lab technology company LBT Innovations (ASX:LBT) has negotiated a less-than-hoped-for minimum royalty deal with licensee bioMérieux worth US$600,000 per year. [ + ]

Melbourne biotech BioDiem (ASX:BDM) has awarded Changchun BCHT an exclusive license for the China private sector market covering its influenza vaccine technology. [ + ]

BDO has advised businesses considering making a claim under the research and development (R&D) Tax Incentive to be aware of the various impending lodgement deadlines imposed by the Australian Government. The network is assisting these businesses with a free online diagnostic tool which indicates eligibility. [ + ]

The genome sequence of the crocodile has been completed by an international collaboration of scientists, including researchers from the University of Sydney. [ + ]

The Victorian Premier’s Award for Health and Medical Research is now open for nominations. [ + ]

Dual-listed biopharma Bioniche (ASX:BNC) has posted a Q2 loss of $4m, and shareholders have been warned the company may have inadequate cash reserves for the next 12 months. [ + ]

Melbourne's Patrys Limited (ASX:PAB) has successfully concluded a safety and tolerability trial for its lead antibody, PAT-SM6, as a melanoma treatment. [ + ]

Increasing the production of proteins that help rid the body of toxins may play a crucial role in the fight against breast and prostate cancer, researchers from Flinders University believe. [ + ]

AusBiotech has today launched the speaking program for the business development meeting of the year, to be held on the Gold Coast from 15-16 March. [ + ]

Two scientists from the Australian Nuclear Science and Technology Organisation (ANSTO) left for Antarctica earlier this week in search of byproducts of cosmic rays colliding with Earth. The scientists are on an environmental mission, working to discover whether a historical relationship exists between solar activity on the sun and climate change on Earth. [ + ]

North Carolina State University researchers have created specially engineered mammalian cells to provide a new ‘chemical handle’ which will enable researchers to label proteins of interest more efficiently, without disrupting the normal function of the proteins themselves or the cells in which they are found. [ + ]